 | 
|
|
 |
||
 |
 |
|
Liste des stages M2 Année 2011-2012
Dernière mise à jour : 29/11/2011
| Titres des stages | ** Stages déja retenus |
|---|---|
| Stage 1 : Bioinformatics analysis of caveolin proteins. | |
| Stage 2 : Criblage de la protéine C, streptokinase et la protéine PPAR’s- Master Training at the Cardiovascular research Institute Maastricht, the Netherlands | **M. Ciantar |
| Stage 3 : Conception et développement d’une nouvelle fonction de scoring OriBase Pharma, Montpellier, France | |
| Stage 4 : Coarse-grained molecular dynamics simulations of nanoparticles | |
| Stage 5 : Linking hot spots in molecular interaction space: Relating ligand descriptors to ligand-protein binding modes - University Amsterdam | ** Louise De Visser |
| Stage 6 : Modélisation du canal potassique hERG (human ether-à-gogo-related gene) | |
| Stage 7 : Détermination d'un modèle pour prédire l’activité des candidats vis-à-vis de la protéine hERG.- University of Copenhagen | ** R. Largen |
| Stage 8 : Antagonists of gankyrin as a treatment for primary liver cancer.- The University of Adelaide | ** K. Druart |
| Stage 9 : Modelling of CDC25 interaction with CDK2-CycA - University of Barcelona | **E. Japaud |
| Stage 10 : Computational study of protein-protein interactions using molecular dynamics and free energy calculations - University of Milano | **G. Nzabonimpa |
| Stage 11 : Computational Drug Discovery group, centre for drug research, faculty of pharmacy (Dr. H. Xhaard) - University of Helsinki | **M. Kuenemann |
| Stage 12 : Computational Pharmaceutical Modeling group, Centre For Drug Research, Faculty of pharmacy (Dr. A. Bunker) - University of Helsinki | **N. Mansouri |
| Stage 13 : The project will involve structural bioinformatic analysis of these proteins to better understand the gain and loss of glycosylation from a structural perspective and potential effect on protein interactions and ligand binding-Departement of Biochemistry & Molecular Biology-GW University- Washington | **LAM NGUYEN Vinh Phuc |
| Stage 14 : Computational Chemistry of Histone Lysine Demethylases and their Inhibitor - Structural Genomics Consortium- Oxford | **JEREMIE Aurore |